Patient Guide: Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 103 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04199689
Status: ACTIVE_NOT_RECRUITING
Condition: Papillomavirus Infections
Phase: PHASE3

Where You Can Participate

This study is available at 103 locations across the country.

Top locations include:
  • • Northridge, California
  • • Rialto, California
  • • Simi Valley, California
  • • And 100 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049) - Join Clinical Trial NCTNCT04199689

How to Join This Clinical Trial - NCTNCT04199689

Learn how to participate in this PHASE3 trial studying an investigational therapy for Papillomavirus Infections. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Papillomavirus Infections. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Papillomavirus Infections
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04199689 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 103 locations. Find a study site near you:

Clinical Research Site

Northridge, California 91325 - United States

Status: Contact for availability

Clinical Research Site

Rialto, California 92377 - United States

Status: Contact for availability

Clinical Research Site

Simi Valley, California 93065 - United States

Status: Contact for availability

Clinical Research Site

Spring Valley, California 91978 - United States

Status: Contact for availability

Clinical Research Site

Walnut Creek, California 94598 - United States

Status: Contact for availability

Clinical Research Site

Coral Gables, Florida 33134 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33142 - United States

Status: Contact for availability

Clinical Research Site

Tampa, Florida 33617 - United States

Status: Contact for availability

Clinical Research Site

Augusta, Georgia 30912 - United States

Status: Contact for availability

Clinical Research Site

Meridian, Idaho 83646 - United States

Status: Contact for availability

And 93 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Papillomavirus Infections:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships